Company's analysis indicates the successful achievement of its proprietary loading technology for producing exosome-based therapies
NurExone is providing an updated release to the previously disseminated
/PRNewswire/ Glaucoma Research Foundation (GRF) today announced a total of $1.3 million in annual research grants to support 10 investigators at prominent.
/PRNewswire/ Glaucoma Research Foundation (GRF) today announced a total of $1.3 million in annual research grants to support 10 investigators at prominent.